DIA: Driving Insights to Action
Science:Life Sciences
The emerging digital healthcare landscape is already becoming quite visible around the world, especially in Japan. But what is the true impact of digital technology on clinical research, drug development, and healthcare? “Imaging data plus AI is one of the best combinations,” explains Dr. Kazuhiro Kanmuri, Founder and Chief Executive Officer of Inter-Professional, Inc. Dr. Kanmuri served on the Program Committee for the June 2019 DIA Japan Cutting Edge Series Workshop #1.
More Episodes
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
2025-01-17
361
2025-01-17
361
DIA: Your Partner in Life Sciences Training and Development
2024-11-06
255
2024-11-06
255
GPP Experts Explain Authorship Algorithm
2024-04-23
272
2024-04-23
272
"Dossier in the Cloud" Democratizing Global Access
2024-04-02
314
2024-04-02
314
DIA: A Place Where You Can Make a Difference
2024-03-28
253
2024-03-28
253
Retiring TGA Head Maps Australia’s Post-Pandemic Future
2023-07-17
395
2023-07-17
395
Patient Engagement: Evolution of Who Knows What, Part 2
2023-06-14
286
2023-06-14
286
Patient Engagement: Evolution of Who Knows What, Part 1
2023-06-12
428
2023-06-12
428
Rwanda Welcomes African Medicines Agency Home
2022-11-30
603
2022-11-30
603
Will Technology Solve the Research “People Problem”?
2022-11-22
376
2022-11-22
376
Why Trans/Nonbinary Research Benefits All Communities
2022-11-18
495
2022-11-18
495
Digital Revolutionizing Data-Driven Reimbursement
2022-10-20
402
2022-10-20
402
China Sets New Record for Local Drug Approvals in 2021
2022-09-15
435
2022-09-15
435
WHO Pilot Formalizes CSA Process to Assist Developers
2022-08-02
427
2022-08-02
427
Get this podcast on your
phone, FREE
